RIZZO, Sabrina
 Distribuzione geografica
Continente #
NA - Nord America 284
EU - Europa 193
AS - Asia 69
AF - Africa 4
SA - Sud America 2
Totale 552
Nazione #
US - Stati Uniti d'America 281
IT - Italia 164
SG - Singapore 33
CN - Cina 19
ID - Indonesia 13
CZ - Repubblica Ceca 6
DE - Germania 6
FR - Francia 4
GB - Regno Unito 4
MA - Marocco 4
CR - Costa Rica 3
FI - Finlandia 3
SE - Svezia 3
BE - Belgio 2
IN - India 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
RO - Romania 1
TW - Taiwan 1
Totale 552
Città #
Ferrara 69
Fairfield 45
Woodbridge 21
Chandler 19
Ashburn 17
Bologna 17
Milan 17
Shanghai 16
Singapore 16
Ann Arbor 14
Jakarta 13
Wilmington 13
Seattle 11
Ferrara di Monte Baldo 10
New York 10
Princeton 10
Cambridge 9
Houston 9
Brno 6
Boardman 5
San Diego 5
Florence 4
Rome 4
Falls Church 3
Frankfurt am Main 3
Lappeenranta 3
Los Angeles 3
Verona 3
Ariano nel Polesine 2
Bondeno 2
Brussels 2
Catania 2
Hangzhou 2
Palermo 2
Pune 2
San José 2
San Zenone degli Ezzelini 2
Sceaux 2
Siena 2
Washington 2
Addison 1
Alajuela 1
Barletta 1
Bentivoglio 1
Chicago 1
Chieti 1
Cochabamba 1
Genoa 1
Hamburg 1
Hounslow 1
Islington 1
Kilburn 1
London 1
Modena 1
Redmond 1
Rennes 1
Taipei 1
Zhengzhou 1
Totale 417
Nome #
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway 126
TLR3 and TLR7 RNA Sensor Activation during SARS-COV-2 Infection 49
SARS-CoV-2 INFECTION: EFFECT ON HOST IMMUNE SYSTEM AND ATYPICAL COVID-19 ASSOCIATED-DISEASES 44
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 37
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 34
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 29
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 28
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 27
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection 26
Effect of SARS-CoV-2 infection in pregnancy on CD147, ACE2 and HLA-G expression 24
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus 22
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 21
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 21
Role of KIR Receptor in NK Regulation during Viral Infections 21
Innate Immune Response in SARS-CoV-2 Infection 17
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 16
Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma 13
Humoral and adaptive immune responses to SARS-CoV-2 vaccine 13
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS 10
Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections 9
Ozonated Oil in Liposome Eyedrops Reduces the Formation of Biofilm, Selection of Antibiotic-Resistant Bacteria, and Adhesion of Bacteria to Human Corneal Cells 7
Non-classical HLA class I molecules and their potential role in viral infections 4
Endocrine Disruptors, Epigenetic Changes, and Transgenerational Transmission 4
Gestational Viral Infections: Role of Host Immune System 3
SARS-CoV-2 Systemic Effects: New Clues 3
SARS-CoV-2 presence in recreational seawater and evaluation of intestine permeability: experimental evidence of low impact on public health 3
Totale 611
Categoria #
all - tutte 6.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 77
Totale 6.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021105 0 4 3 68 1 12 2 0 1 3 2 9
2021/202294 0 0 15 4 5 12 8 2 11 3 10 24
2022/2023121 15 4 12 3 5 4 21 14 17 0 25 1
2023/2024265 11 27 16 5 24 17 12 19 17 19 23 75
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 611